Stemirna Therapeutics Halts mRNA Vaccine Factory Construction Amid Low Demand
China-based Stemirna Therapeutics Co., Ltd has decided to halt the construction of a factory intended...
China-based Stemirna Therapeutics Co., Ltd has decided to halt the construction of a factory intended...
China-based Alphamab Oncology (HKG: 9966) has announced a strategic partnership with Shanghai-based mRNA drug developer...
Stemirna Therapeutics Co., Ltd, an mRNA drug developer based in Shanghai, has obtained Emergency Use...